Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03674814
Title Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

prostate cancer

Therapies

Enzalutamide + Relacorilant

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University Of Chicago Medicine Comprehensive Cancer Center Recruiting Chicago Illinois 60637 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field